SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-085270
Filing Date
2020-07-21
Accepted
2020-07-21 16:13:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2025297d1_424b5.htm 424B5 295908
2 GRAPHIC tm2025297d1_424b5img001.jpg GRAPHIC 9630
3 GRAPHIC tm2025297d1_424b5img002.jpg GRAPHIC 52677
  Complete submission text file 0001104659-20-085270.txt   383108
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-222046 | Film No.: 201039024
SIC: 2836 Biological Products, (No Diagnostic Substances)